SAN FRANCISCO (Thomson Financial) - EpiCept Corp. said Tuesday its public
offering of 3.33 million shares has priced at $1.50 a share, along with
five-year warrants to purchase up to roughly 1.67 million shares at an exercise
price of $1.50 each.
Tarrytown, N.Y.-based EpiCept, a pharmaceutical company, said it will
receive roughly $4.7 million in net proceeds from the offering.
EpiCept plans to use the proceeds for general corporate purposes.
Shares of EpiCept fell 1 cent to $1.41.
Gabriel Madway
gm/jw
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|